Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

clinical health data

Measuring Vital Health Indicators Through Your Camera

Dr. Keith Thompson, CMO at Nuralogix, dives into virtual care, telemedicine, and advanced digital health tools for improving primary care workflows and population health. He also shares his insights into...

Impetus Digital

- PMLiVE

Celltrion submits application for inhaled COVID-19 antibody treatment

A global phase 3 clinical study will evaluate the inhaled antibody cocktail treatment for patients with mild-to-moderate COVID-19 symptoms

- PMLiVE

Six million patients affected by delay to NHS England’s plans to address COVID-19 backlog

UK’s health and social care secretary Sajid Javid said that the number of patients on these hospital waiting lists would increase before beginning to fall

- PMLiVE

MHRA issues CMA for Novavax COVID-19 vaccine

Nuvaxovid offers up to 89% protection against COVID-19

VR/AR Applications for Training and Healthcare

Mike Waldron, CEO and Co-Founder of Propel VR, discusses how virtual reality (VR) and augmented reality (AR) can be leveraged in the healthcare industry, including specific applications of VR/AR for...

Impetus Digital

Forging Innovative Solutions by Merging Art and Science

Ariel Garten, Founder & Chief Evangelism Officer at Muse, explores many exciting topics such as the idea of whether art and beauty can be broken down into biological codes, the...

Impetus Digital

- PMLiVE

New Omicron subvariant appears more transmissible but no more severe than original Omicron strain

The new subvariant is already emerging as a dominant strain in Denmark, the Philippines, Nepal, Qatar and India

- PMLiVE

Pfizer’s Paxlovid receives positive opinion from CHMP

If authorised, the drug would be the first COVID-19 oral treatment recommended in the EU

- PMLiVE

Moderna begins phase 2 trial of Omicron-specific booster

The study will include two groups, with approximately 300 people in each group

Expanding Access to High-Quality Healthcare

Dr. Jason Cross, Co-founder & Chief Strategy Officer at Rymedi, dives into Connected Health, including how it can be used to expand access to high-quality healthcare, current barriers to its...

Impetus Digital

- PMLiVE

Pfizer and BioNTech start clinical trial for Omicron-based COVID-19 vaccine

The clinical trial involves adults aged 18 to 55 who received an Omicron-based vaccine candidate as part of a two-dose primary series, as well as a booster

- PMLiVE

FDA restricts use of certain antibody treatments for COVID-19

The restrictions reflect recent data that shows these antibodies are not effective against the Omicron variant

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links